These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35987038)

  • 21. Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study.
    Zhong M; Zhu S; Gu R; Wang Y; Jiang Y; Bai Y; Jiang X; Shen B; Yan J; Pan Y; Zhu J; Zhang L
    Behav Neurol; 2022; 2022():4797861. PubMed ID: 35295686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.
    Specketer K; Zabetian CP; Edwards KL; Tian L; Quinn JF; Peterson-Hiller AL; Chung KA; Hu SC; Montine TJ; Cholerton BA
    J Clin Exp Neuropsychol; 2019 Oct; 41(8):803-813. PubMed ID: 31177941
    [No Abstract]   [Full Text] [Related]  

  • 23. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression symptomatology correlates with event-related potentials in Parkinson's disease: An affective priming study.
    Dissanayaka NNW; Au TR; Angwin AJ; Iyer KK; O'Sullivan JD; Byrne GJ; Silburn PA; Marsh R; Mellick GD; Copland DA
    J Affect Disord; 2019 Feb; 245():897-904. PubMed ID: 30699874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Executive functions are impaired in patients with Parkinson's disease with visual hallucinations.
    Barnes J; Boubert L
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):190-2. PubMed ID: 18202206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease.
    Shine JM; Halliday GM; Gilat M; Matar E; Bolitho SJ; Carlos M; Naismith SL; Lewis SJ
    Hum Brain Mapp; 2014 May; 35(5):2206-19. PubMed ID: 23760982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of stimulus-response compatibility in Parkinson's disease: a psychophysiological analysis.
    Falkenstein M; Willemssen R; Hohnsbein J; Hielscher H
    J Neural Transm (Vienna); 2006 Oct; 113(10):1449-62. PubMed ID: 16465455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease.
    Chung EJ; Seok K; Kim SJ
    Clin Neurol Neurosurg; 2015 Mar; 130():98-100. PubMed ID: 25596487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pattern of attentional deficits in Parkinson's disease.
    Dujardin K; Tard C; Duhamel A; Delval A; Moreau C; Devos D; Defebvre L
    Parkinsonism Relat Disord; 2013 Mar; 19(3):300-5. PubMed ID: 23196037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual Priming and Visual Hallucinations in Parkinson's Disease. Evidence for Normal Top-Down Processes.
    Straughan S; Collerton D; Bruce V
    J Geriatr Psychiatry Neurol; 2016 Jan; 29(1):25-30. PubMed ID: 26232406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study.
    Babiloni C; Pascarelli MT; Lizio R; Noce G; Lopez S; Rizzo M; Ferri R; Soricelli A; Nobili F; Arnaldi D; Famà F; Orzi F; Buttinelli C; Giubilei F; Salvetti M; Cipollini V; Bonanni L; Franciotti R; Onofrj M; Stirpe P; Fuhr P; Gschwandtner U; Ransmayr G; Aarsland D; Parnetti L; Farotti L; Marizzoni M; D'Antonio F; De Lena C; Güntekin B; Hanoğlu L; Yener G; Emek-Savaş DD; Triggiani AI; Taylor JP; McKeith I; Stocchi F; Vacca L; Hampel H; Frisoni GB; De Pandis MF; Del Percio C
    Neurobiol Aging; 2020 Jul; 91():88-111. PubMed ID: 32234263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining visual illusions in Parkinson's disease: Kinetopsia and object misidentification illusions.
    Nishio Y; Yokoi K; Hirayama K; Ishioka T; Hosokai Y; Gang M; Uchiyama M; Baba T; Suzuki K; Takeda A; Mori E
    Parkinsonism Relat Disord; 2018 Oct; 55():111-116. PubMed ID: 29891431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
    Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
    Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural correlates of attentional deficits in Parkinson's disease patients with mild cognitive impairment.
    Yang J; Pourzinal D; McMahon KL; Byrne GJ; Copland DA; O'Sullivan JD; Dissanayaka NN
    Parkinsonism Relat Disord; 2021 Apr; 85():17-22. PubMed ID: 33647838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flanker compatibility effects in patients with Parkinson's disease: impact of target onset delay and trial-by-trial stimulus variation.
    Cagigas XE; Filoteo JV; Stricker JL; Rilling LM; Friedrich FJ
    Brain Cogn; 2007 Apr; 63(3):247-59. PubMed ID: 17049703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
    Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
    J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; de Jong BM; Renken R; Leenders KL; Cornelissen FW; van Laar T
    Brain; 2009 Nov; 132(Pt 11):2980-93. PubMed ID: 19755518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Early Attentional Processes in Parkinson's Disease: A High-Resolution Event-Related Potentials Study.
    Bocquillon P; Bourriez JL; Palmero-Soler E; Defebvre L; Derambure P; Dujardin K
    PLoS One; 2015; 10(7):e0131654. PubMed ID: 26135906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of Parkinson's disease on interference control during action selection.
    Wylie SA; van den Wildenberg WP; Ridderinkhof KR; Bashore TR; Powell VD; Manning CA; Wooten GF
    Neuropsychologia; 2009 Jan; 47(1):145-57. PubMed ID: 18761363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.